Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Health-related quality of life and patient-centred outcomes with olaparib maintenance after chemotherapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT Ov-21): a placebo-controlled, phase 3 randomised trial.

Friedlander M, Gebski V, Gibbs E, Davies L, Bloomfield R, Hilpert F, Wenzel LB, Eek D, Rodrigues M, Clamp A, Penson RT, Provencher D, Korach J, Huzarski T, Vidal L, Salutari V, Scott C, Nicoletto MO, Tamura K, Espinoza D, Joly F, Pujade-Lauraine E.

Lancet Oncol. 2018 Aug;19(8):1126-1134. doi: 10.1016/S1470-2045(18)30343-7. Epub 2018 Jul 17.

PMID:
30026002
2.

Disparities in health-related quality of life in women undergoing treatment for advanced ovarian cancer: the role of individual-level and contextual social determinants.

Moss JL, Murphy J, Filiaci VL, Wenzel LB, Minasian L, Temkin SM.

Support Care Cancer. 2019 Feb;27(2):531-538. doi: 10.1007/s00520-018-4340-9. Epub 2018 Jul 12.

PMID:
30003341
3.

Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240).

Penson RT, Huang HQ, Wenzel LB, Monk BJ, Stockman S, Long HJ 3rd, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, Method M, Michael H, Tewari KS.

Lancet Oncol. 2015 Mar;16(3):301-11. doi: 10.1016/S1470-2045(15)70004-5. Epub 2015 Jan 29. Erratum in: Lancet Oncol. 2016 Jan;17(1):e6.

4.
5.

Longitudinal change in telomere length and the chronic stress response in a randomized pilot biobehavioral clinical study: implications for cancer prevention.

Biegler KA, Anderson AK, Wenzel LB, Osann K, Nelson EL.

Cancer Prev Res (Phila). 2012 Oct;5(10):1173-82. doi: 10.1158/1940-6207.CAPR-12-0008. Epub 2012 Jul 24.

6.

Quality-of-life results used to endorse changes in standard of care for recurrent platinum-sensitive ovarian cancer.

Chase DM, Wenzel LB, Monk BJ.

Expert Rev Pharmacoecon Outcomes Res. 2012 Jun;12(3):279-81. doi: 10.1586/erp.12.22.

7.

The association between quality of life domains and overall survival in ovarian cancer patients during adjuvant chemotherapy: a Gynecologic Oncology Group Study.

von Gruenigen VE, Huang HQ, Gil KM, Frasure HE, Armstrong DK, Wenzel LB.

Gynecol Oncol. 2012 Mar;124(3):379-82. doi: 10.1016/j.ygyno.2011.11.032. Epub 2011 Nov 23.

8.

Survivorship as an element of clinical trials in ovarian cancer.

McAlpine JN, Wenzel LB; Gynecologic Cancer InterGroup.

Int J Gynecol Cancer. 2011 May;21(4):788-92. doi: 10.1097/IGC.0b013e31821bb717. Review. No abstract available.

9.

Stress, immunity, and cervical cancer: biobehavioral outcomes of a randomized clinical trial [corrected].

Nelson EL, Wenzel LB, Osann K, Dogan-Ates A, Chantana N, Reina-Patton A, Laust AK, Nishimoto KP, Chicz-DeMet A, du Pont N, Monk BJ.

Clin Cancer Res. 2008 Apr 1;14(7):2111-8. doi: 10.1158/1078-0432.CCR-07-1632. Erratum in: Clin Cancer Res. 2008 May 1;14(9):2892.

10.

Supportive care for women with gynecologic cancers.

Chase DM, Monk BJ, Wenzel LB, Tewari KS.

Expert Rev Anticancer Ther. 2008 Feb;8(2):227-41. doi: 10.1586/14737140.8.2.227. Review.

11.

Health-related quality of life in a racially diverse population screened for hemochromatosis: results from the Hemochromatosis and Iron Overload Screening (HEIRS) study.

Wenzel LB, Anderson R, Tucker DC, Palla S, Thomson E, Speechley M, Harrison H, Lewis-Jack O, Fadojutimi-Akinsiku M, Eckfeldt JH, Reiss JA, Rivers CA, Bookman E, Snively BM, McLaren CE; Hemochromatosis and Iron Overload Study Research Investigators.

Genet Med. 2007 Oct;9(10):705-12.

PMID:
18073584
12.

Clinical trial endpoints in ovarian cancer: report of an FDA/ASCO/AACR Public Workshop.

Bast RC, Thigpen JT, Arbuck SG, Basen-Engquist K, Burke LB, Freedman R, Horning SJ, Ozols R, Rustin GJ, Spriggs D, Wenzel LB, Pazdur R.

Gynecol Oncol. 2007 Nov;107(2):173-6.

PMID:
17950384
13.

Health-related quality of life during and after intraperitoneal versus intravenous chemotherapy for optimally debulked ovarian cancer: a Gynecologic Oncology Group Study.

Wenzel LB, Huang HQ, Armstrong DK, Walker JL, Cella D; Gynecologic Oncology Group.

J Clin Oncol. 2007 Feb 1;25(4):437-43.

PMID:
17264340
14.

Quality of life considerations in gynecologic cancer. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

Penson RT, Wenzel LB, Vergote I, Cella D.

Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S247-57. Review.

PMID:
17161164
15.

Quality of Life Considerations in Gynecologic Cancer.

Penson RT, Wenzel LB, Vergote I, Cella D.

Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S247-S257. doi: 10.1016/S0020-7292(06)60040-4.

PMID:
29644666
16.

Cervical cancer.

Basen-Engquist K, Paskett ED, Buzaglo J, Miller SM, Schover L, Wenzel LB, Bodurka DC.

Cancer. 2003 Nov 1;98(9 Suppl):2009-14. Review.

17.

Randomized, controlled trial of an easy-to-read informed consent statement for clinical trial participation: a study of the Eastern Cooperative Oncology Group.

Coyne CA, Xu R, Raich P, Plomer K, Dignan M, Wenzel LB, Fairclough D, Habermann T, Schnell L, Quella S, Cella D; Eastern Cooperative Oncology Group.

J Clin Oncol. 2003 Mar 1;21(5):836-42.

PMID:
12610182
18.

Resilience, reflection, and residual stress in ovarian cancer survivorship: a gynecologic oncology group study.

Wenzel LB, Donnelly JP, Fowler JM, Habbal R, Taylor TH, Aziz N, Cella D.

Psychooncology. 2002 Mar-Apr;11(2):142-53.

PMID:
11921330
19.

Age-related differences in the quality of life of breast carcinoma patients after treatment.

Wenzel LB, Fairclough DL, Brady MJ, Cella D, Garrett KM, Kluhsman BC, Crane LA, Marcus AC.

Cancer. 1999 Nov 1;86(9):1768-74.

PMID:
10547550
20.

Telephone counseling of breast cancer patients after treatment: a description of a randomized clinical trial.

Marcus AC, Garrett KM, Cella D, Wenzel LB, Brady MJ, Crane LA, McClatchey MW, Kluhsman BC, Pate-Willig M.

Psychooncology. 1998 Nov-Dec;7(6):470-82.

PMID:
9885088
21.

Psychological, social and sexual effects of gestational trophoblastic disease on patients and their partners.

Wenzel LB, Berkowitz RS, Robinson S, Goldstein DP, Bernstein MR.

J Reprod Med. 1994 Mar;39(3):163-7. Review.

PMID:
8035371

Supplemental Content

Loading ...
Support Center